Medical Research News and Research

RSS

Scientists discover evolutionary lineage of SARS-CoV-2 virus

By reconstructing the evolutionary history of SARS-CoV-2, the virus that is responsible for the COVID-19 pandemic, an international research team of Chinese, European and U.S. scientists has discovered that the lineage that gave rise to the virus has been circulating in bats for decades and likely includes other viruses with the ability to infect humans.

29 Jul 2020

Researchers uncover a novel mechanism by which cancer cells adapt to stress

Collaborative Cancer Research UK-funded studies from University of Oxford researchers have uncovered a new mechanism by which cancer cells adapt to the stresses they encounter as they grow and respond to therapies.

29 Jul 2020

New approach is more effective in treating certain blood cancers

Some of the most promising advances in cancer treatment have centered on immunotherapies that rev up a patient's immune system to attack cancer.

24 Jul 2020

Study shows neo-self antibody as major cause of recurrent pregnancy loss

A research group centered around Kobe University Graduate School of Medicine's Professor YAMADA Hideto and Associate Professor TANIMURA Kenji (Department of Obstetrics and Gynecology), and Professor ARASE Hisashi et al. of Osaka University's Research Institute for Microbial Diseases have revealed for the first time in the world the high frequency of a novel autoantibody in women suffering from recurrent pregnancy loss.

23 Jul 2020

Novel genetic measure could improve screening for osteoporosis

An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility.

22 Jul 2020

Study: High levels of iron in the blood can prevent age-related damage

Genes linked to ageing that could help explain why some people age at different rates to others has been identified by scientists.

17 Jul 2020

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.

15 Jul 2020

UVA scientists identify oncogene responsible for glioblastoma

Scientists have identified an oncogene (a cancer-causing gene) responsible for glioblastoma, the deadliest brain tumor.

15 Jul 2020

High amount of SARS-Cov-2 receptor is present in patients with pre-existing cardiac conditions

Nearly 20% of all COVID-19-associated deaths are from cardiac complications, yet the mechanisms from which these complications arise have remained a topic of debate in the cardiology community.

15 Jul 2020

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has established a new clinical trial network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

14 Jul 2020

Scientists to develop virtual reality simulator to improve training on hiatal hernia surgery

Baylor Scott & White Research Institute has received funding for a study from the National Institute of Biomedical Imaging and Bioengineering, one of the 27 institutes and centers of the National Institutes of Health (NIH), the nation's premier medical research agency.

14 Jul 2020

Researchers to develop new ways to prevent esophageal cancer

The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent.

14 Jul 2020

Study shows cathepsin B can be used as biomarker for traumatic brain injury

Scientists at the Walter Reed Army Institute for Research (WRAIR) have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.

14 Jul 2020

Modeling research shows increase in HIV, TB, and malaria deaths due to COVID-19 pandemic

But there is still an opportunity to substantially reduce the death toll by prioritizing the most critical services, specifically antiretroviral therapy for HIV, timely TB diagnosis and treatment, and provision of long-lasting insecticide-treated nets for malaria, researchers say.

14 Jul 2020

Single dose of flu drug can limit the spread of the illness within households

A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.

14 Jul 2020

A mapping method to study different cell type changes in developing mouse brains

Penn State researchers have developed a new method for studying key moments in brain development. Yongsoo Kim, assistant professor of neural and behavioral sciences at Penn State College of Medicine, is using the method to understand how oxytocin receptor expression changes in normally developing mice and mouse models of autism spectrum disorder.

14 Jul 2020

Study shows the negative impacts of cannabis use

Constant exposure to cannabis could have an adverse effect on sociability. According to studies, in certain indviduals, such exposures may result in reduced social interactions and withdrawal symptoms.

13 Jul 2020

In vitro cardiotoxicity screening using 3D-printed human heart tissues

Ramot at Tel Aviv University has signed a collaboration agreement with Bayer to develop and validate a platform for in vitro cardiotoxicity screening, using human heart tissues 3D-printed in Prof. Tal Dvir's Laboratory for Tissue Engineering and Regenerative Medicine at Tel Aviv University.

1 Jul 2020

Sanford Burnham Prebys announces research agreement with Lilly to characterize COVID-19 antibodies

Sanford Burnham Prebys Medical Discovery Institute today announced a research agreement with Eli Lilly and Company (Lilly) to characterize Lilly's next-generation anti-SARS-CoV-2 antibodies.

30 Jun 2020

Princeton researcher solves long-standing mysteries of membrane protein structure

Ion channels and membrane transporters are in the business of moving ions and small molecules across cellular membranes. They are essential for metabolic and cellular homeostasis, and for a host of biological signaling pathways.

30 Jun 2020

Medical Research News and Research

Scientists discover evolutionary lineage of SARS-CoV-2 virus

Researchers uncover a novel mechanism by which cancer cells adapt to stress

New approach is more effective in treating certain blood cancers

Study shows neo-self antibody as major cause of recurrent pregnancy loss

Novel genetic measure could improve screening for osteoporosis

Study: High levels of iron in the blood can prevent age-related damage

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

UVA scientists identify oncogene responsible for glioblastoma

High amount of SARS-Cov-2 receptor is present in patients with pre-existing cardiac conditions

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

Scientists to develop virtual reality simulator to improve training on hiatal hernia surgery

Researchers to develop new ways to prevent esophageal cancer

Study shows cathepsin B can be used as biomarker for traumatic brain injury

Modeling research shows increase in HIV, TB, and malaria deaths due to COVID-19 pandemic

Single dose of flu drug can limit the spread of the illness within households

A mapping method to study different cell type changes in developing mouse brains

Study shows the negative impacts of cannabis use

In vitro cardiotoxicity screening using 3D-printed human heart tissues

Sanford Burnham Prebys announces research agreement with Lilly to characterize COVID-19 antibodies

Princeton researcher solves long-standing mysteries of membrane protein structure

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Latest in Genomics